Lloyd M. Segal's most recent trade in Repare Therapeutics Inc was a trade of 21,179 Common Shares done at an average price of $1.1 . Disclosure was reported to the exchange on March 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 12 Mar 2025 | 21,179 | 124,394 | - | 1.1 | 24,144 | Common Shares | |
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 04 Mar 2025 | 237,000 | 237,000 | - | - | Employee Stock Option (right to buy) | ||
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 04 Mar 2025 | 40,000 | 145,573 | - | 0 | Common Shares | ||
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 28 Mar 2024 | 2,650 | 110,049 | - | 4.6 | 12,243 | Common Shares | |
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 28 Mar 2024 | 2,491 | 107,558 | - | 4.6 | 11,533 | Common Shares | |
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 25 Mar 2024 | 2,650 | 83,866 | - | 4.6 | 12,270 | Common Shares | |
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 25 Mar 2024 | 2,650 | 89,166 | - | 4.8 | 12,694 | Common Shares | |
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 25 Mar 2024 | 2,650 | 86,516 | - | 4.6 | 12,296 | Common Shares | |
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 01 Mar 2024 | 237,000 | 237,000 | - | - | Employee Stock Option (right to buy) | ||
| Repare Therapeutics Inc | Lloyd M. Segal | Director, PRESIDENT AND CEO | 01 Mar 2024 | 40,000 | 124,677 | - | 0 | Common Shares | ||
| Repare Therapeutics Inc | Lloyd M. Segal | Director, President and CEO | 30 Jan 2023 | 344,200 | 344,200 | - | - | Employee Stock Option (right to buy) | ||
| Repare Therapeutics Inc | Lloyd M. Segal | Director, President and CEO | 30 Jan 2023 | 78,550 | 84,677 | - | 0 | Common Shares | ||
| Repare Therapeutics Inc | Lloyd M. Segal | Director, President and CEO | 21 Jan 2022 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | ||
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 28 Jun 2021 | 1,542 | 94,466 | - | 35.6 | 54,911 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 09 Jun 2021 | 1,576 | 96,008 | - | 35 | 55,160 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 03 Jun 2021 | 17,180 | 109,756 | - | 30.6 | 526,395 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 03 Jun 2021 | 12,172 | 97,584 | - | 31.4 | 381,714 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 03 Jun 2021 | 6,648 | 126,936 | - | 31.7 | 211,008 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 03 Jun 2021 | 5,000 | 283,683 | - | - | Employee Stock Option (right to buy) | ||
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 03 Jun 2021 | 5,000 | 5,000 | - | 31.3 | 156,250 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 03 Jun 2021 | 5,000 | 10,000 | - | 1.6 | 8,185 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 20 May 2021 | 3,770 | 133,584 | - | 35.0 | 132,065 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 18 May 2021 | 3,800 | 137,354 | - | 35.1 | 133,228 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 18 May 2021 | 1,800 | 141,154 | - | 35 | 63,000 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 15 Apr 2021 | 5,512 | 142,954 | - | 35.0 | 192,975 | Common Stock | |
| Repare Therapeutics Inc | Lloyd M. Segal | President and CEO | 08 Feb 2021 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) |